long term effects of glp 1 drugs Part 2 of a 3-Part Series; GLP-1 GLP-1 Weight Loss Drugs Under

Description

They stand up to any scientific scrutiny

Learn why experts say it's a "real-time experiment" you shouldn't risk.

Randomized controlled trials (RCTs) comparing insulin with established GLP-1 RAs, DPP-4is, or SGLT-2is were included

Very few include older adults at high risk

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk